Janku Filip bought GLUE
June 24, 2026 · Form 4 insider transaction
Janku Filip bought 30,000 shares of Monte Rosa Therapeutics, Inc. at $7.56 per share, a transaction worth $226.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$7.56
Total value
$226.8K
InsiderJanku Filip
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 24, 2026
Filing dateJune 25, 2026
Shares owned after89,992
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2026.